IE 11 is a very old Browser and it`s not supported on this site

Consolidated statement of changes in equity for the year ended December 31

in CHF 1 000

 

Share capital

 

Treasury shares

 

Retained earnings

 

Total

Balances at January 1, 2021

 

11 080

 

(8 241)

 

3 884 708

 

3 887 547

Dividend (CHF 3.60 per share)

 

 

 

(199 440)

 

(199 440)

Trade with treasury shares

 

 

(964)

 

1 158

 

194

Total comprehensive income for the period

 

 

 

(404 808)

 

(404 808)

Balances at December 31, 2021

 

11 080

 

(9 205)

 

3 281 618

 

3 283 493

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balances at January 1, 2022

 

11 080

 

(9 205)

 

3 281 618

 

3 283 493

Dividend (CHF 3.85 per share)

 

 

 

(212 242)

 

(212 242)

Trade with treasury shares

 

 

(27 303)

 

 

(27 303)

Total comprehensive income for the period

 

 

 

(357 812)

 

(357 812)

Balances at December 31, 2022

 

11 080

 

(36 508)

 

2 711 563

 

2 686 135

The notes are an integral part of the consolidated financial statements.

BB Biotech AG uses cookies to improve website usability and ensure the best possible user experience. Use of cookies & disclaimer